MEDIMMUNE, WYETH TO LAUNCH RESPIGAM FOR RSV PROPHYLAXIS IN SEPTEMBER WITH PARENT EDUCATION; PHARMACOECONOMIC STUDIES WILL BE PROMOTED TO MCOs

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".